Melanoma (stage III or IV) - ipilimumab: Bristol Myers-Squibb - supplementary letter

Melanoma (stage III or IV) - ipilimumab: Bristol Myers-Squibb - supplementary letter

Melanoma (stage III or IV) - ipilimumab: Bristol Myers-Squibb - supplementary letter
02 November 2012
(17.98 Kb 5 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 31 October 2012